Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Performax Labs Inc
WARNING LETTER
•Performax Labs Inc•May 9, 2022

FDA WARNING_LETTER - Performax Labs Inc - May 09, 2022

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Warning Letter, dated May 4, 2022, addresses the products Brute BCAA and Predator Pro, labeled as dietary supplements. The FDA determined these products are adulterated under the Federal Food, Drug, and Cosmetic Act (FD&C Act) because they contain an unsafe food additive.

The core violation is the inclusion of 5-alpha-hydroxy-laxogenin, declared as a dietary ingredient on the product labels. The FDA asserts that 5-alpha-hydroxy-laxogenin does not meet the definition of a dietary ingredient as per section 201(ff)(1) of the FD&C Act. Since it is not a dietary ingredient and is not generally recognized as safe (GRAS) for its intended use, nor does it qualify for other exemptions, it is considered an unapproved food additive.

Under section 402(a)(2)(C)(i) of the FD&C Act, any food containing an unsafe food additive is deemed adulterated. The introduction or delivery of adulterated food into interstate commerce is a prohibited act under section 301(a) of the Act.

The letter requires a written response within fifteen working days, detailing specific corrective actions taken to address the violations and prevent recurrence, along with supporting documentation. Failure to comply may result in legal action, including seizure and injunction.

Company
Performax Labs Inc
Inspection Date
May 9, 2022
Product Type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • Ann M. Oxenham (Director)
Open in Dashboard

ID · 32ca0ae0-f429-4281-b4f5-4dd645f52757

Violation Codes4
21 U.S.C. 331(a)21 U.S.C. 321(ff)(1)21 U.S.C. 342(a)(2)(C)(i)21 U.S.C. 321(s)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.